We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+7.98%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$6.25B
AUM Growth
-$1.7B
Cap. Flow
-$2.08B
Cap. Flow %
-33.31%
Top 10 Hldgs %
54.24%
Holding
331
New
77
Increased
88
Reduced
65
Closed
73

Top Buys

Rank Stock Value
1
FIVN icon
FIVE9
FIVN
+$41.6M
2
NARI
Inari Medical, Inc. Common Stock
NARI
+$39M
3
DPZ icon
Domino's
DPZ
+$33.2M
4
INCY icon
Incyte
INCY
+$27.6M
5
HUM icon
Humana
HUM
+$26.5M

Top Sells

Rank Stock Value
1
NBIX icon
Neurocrine Biosciences
NBIX
+$109M
2
EXAS
Exact Sciences
EXAS
+$59.2M
3
SNY icon
Sanofi
SNY
+$49.7M
4
KDP icon
Keurig Dr Pepper
KDP
+$49.6M
5
GSK icon
GSK
GSK
+$39.9M

Sector Composition

Rank Sector Weight
1 Healthcare 41.55%
2 Consumer Discretionary 7.13%
3 Consumer Staples 5.35%
4 Technology 5.24%
5 Communication Services 0.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MBRX icon
176
Moleculin Biotech
MBRX
$2.76M
$824K 0.01%
11,600
+5,360
+86% +$386K
IKT icon
177
Inhibikase Therapeutics
IKT
$377M
$814K 0.01%
626,500
+36,925
+6% +$49.4K
APTO
178
DELISTED
Aptose Biosciences, Inc.
APTO
$776K 0.01%
62,933
+5,833
+10% +$88.8K
PWCM
179
PowerCompute, Inc. Common Stock
PWCM
$1.45M
$737K 0.01%
+11,080
New +$911K
NEUP
180
Neuphoria Therapeutics
NEUP
$21M
$700K 0.01%
132,750
+30,520
+30% +$242K
GROY.WS icon
181
Gold Royalty Corp Warrants
GROY.WS
$170M
$660K 0.01%
2,200,000
– –
XRT icon
182
State Street SPDR S&P Retail ETF
XRT
$329M
$657K 0.01%
8,459
-323
-4% -$24.4K
TPR icon
183
Tapestry
TPR
$32.2B
$656K 0.01%
+13,967
New +$576K
VIVS
184
VivoSim Labs
VIVS
$1.27M
$620K 0.01%
101,500
+24,083
+31% +$168K
EVGN icon
185
Evogene
EVGN
$7.64M
$598K 0.01%
+194,692
New +$840K
MO icon
186
Altria Group
MO
$114B
$577K 0.01%
11,310
+3,259
+40% +$165K
VCNX
187
DELISTED
Vaccinex, Inc. Common Stock
VCNX
$558K 0.01%
164,000
+70,000
+74% +$394K
AYTU icon
188
AYTU BioPharma
AYTU
$24.7M
$555K 0.01%
236,000
-16,000
-6% -$41.4K
KRE icon
189
State Street SPDR S&P Regional Banking ETF
KRE
$4.71B
$553K 0.01%
+9,766
New +$536K
BNTC icon
190
Benitec Biopharma
BNTC
$436M
$551K 0.01%
+60,000
New +$537K
CNK icon
191
Cinemark Holdings
CNK
$4.38B
$550K 0.01%
+19,740
New +$502K
PG icon
192
Procter & Gamble
PG
$341B
$523K 0.01%
+3,017
New +$512K
TSN icon
193
Tyson Foods
TSN
$20.5B
$459K 0.01%
+7,701
New +$470K
TFFP
194
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
$458K 0.01%
228,000
+42,305
+23% +$83.3K
PIXY
195
DELISTED
ShiftPixy, Inc. Common Stock
PIXY
$449K 0.01%
+36,077
New +$695K
BKNG icon
196
Booking.com
BKNG
$156B
$425K 0.01%
+2,525
New +$387K
CHTR icon
197
Charter Communications
CHTR
$18.3B
$380K 0.01%
+1,174
New +$395K
WINT
198
DELISTED
Windtree Therapeutics
WINT
$375K 0.01%
+3,140
New +$948K
CLX icon
199
Clorox
CLX
$12.8B
$374K 0.01%
2,295
-2,243
-49% -$332K
ANF icon
200
Abercrombie & Fitch
ANF
$4.86B
$369K 0.01%
2,640
+1,427
+118% +$217K
6 7
8
9 10

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return
PI
PGGM Investments Zeist, Netherlands $5.7B AUM 17.05% 1-Year Est. Return

Armistice Capital's Q3 2024 Portfolio in Review

As of Q3 2024, Armistice Capital held 331 positions worth $6.25B, down 21% from $7.95B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Armistice Capital withdrew a net $2.08B in Q3 2024, closing 73 positions and reducing 65 holdings. Its most notable exit was Exact Sciences, an estimated $59.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 42% of assets, up from 33% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

Against the trend, Armistice Capital opened a new position in Paramount Global Class B worth $21.2M.

  • Armistice Capital's largest Q3 2024 buy was Paramount Global Class B: 2,000,000 shares worth $21.2M.
  • Armistice Capital added most to FIVE9 in Q3 2024, an estimated $41.6M increase.
  • Armistice Capital's biggest Q3 2024 reduction was Neurocrine Biosciences, cutting an estimated $109M.
  • Armistice Capital fully exited Exact Sciences in Q3 2024, selling an estimated $59.2M.
  • Armistice Capital's ten largest holdings make up 54% of its $6.25B portfolio in Q3 2024.
  • Armistice Capital opened 77 new positions and closed 73 in Q3 2024.
  • Armistice Capital's portfolio value fell 21% quarter-over-quarter to $6.25B.

Based on Armistice Capital's 13F filing for Q3 2024, filed 14 Nov 2024.